Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-76
Closed -$9.77K 238
2023
Q2
$9.77K Hold
76
﹤0.01% 393
2023
Q1
$8.83K Hold
76
﹤0.01% 403
2022
Q4
$8.61K Buy
76
+56
+280% +$6.15K ﹤0.01% 388
2022
Q3
$2K Hold
20
﹤0.01% 479
2022
Q2
$2K Hold
20
﹤0.01% 533
2022
Q1
$3K Hold
20
﹤0.01% 418
2021
Q4
$3K Buy
+20
New +$2.87K ﹤0.01% 425
2021
Q2
$2K Hold
20
﹤0.01% 405
2021
Q1
$2K Buy
+20
New +$1.88K ﹤0.01% 367

Other funds holding DXCM

Horan Securities's DXCM Position: Q3 2023 in Review

Horan Securities sold out of DexCom (DXCM) in Q3 2023, closing a stake of 76 shares — an estimated $9.77K sold.

Horan Securities first reported a position in DXCM in Q1 2021 and held it in 9 quarters. The position peaked at $9.77K in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Horan Securities reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 76 DexCom shares in Q3 2023, an estimated $9.77K.
  • Horan Securities first reported a position in DexCom in Q1 2021 and held it in 9 quarters.
  • Horan Securities's DexCom position peaked at $9.77K in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.